162.71MMarket Cap-5361P/E (TTM)
2.1000High1.9700Low113.30KVolume1.9900Open1.9900Pre Close231.30KTurnover0.20%Turnover RatioLossP/E (Static)81.35MShares3.290052wk High3.69P/B114.98MFloat Cap1.110052wk Low--Dividend TTM57.49MShs Float27.6000Historical High--Div YieldTTM6.53%Amplitude0.5300Historical Low2.0410Avg Price1Lot Size
ProQR Therapeutics Stock Forum
NEWS
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical data for its AX-0810 pipelin...
ProQR Therapeutics Highlights New Platform Data From Presentation On Axiomer RNA Editing Technology, Company Says Platform Demonstrates Robust In Vivo Editing Capabilities Reporting Up To 70% Editing
Long Term Pharma Holds
1. $Viking Therapeutics(VKTX.US)$ closest competitor to $Madrigal Pharmaceuticals(MDGL.US)$ , which recently announced breakthroughs in the NASH space and price went up ×4 times. multiple catalysts in 2023 q1.
2. $ProQR Therapeutics(PRQR.US)$ announced collaboration with LLY, their RNAI editing softwa...
AH + 12/23 watchlist
$AMC Entertainment(AMC.US)$$AppTech Payments(APCX.US)$$Core Scientific(CORZ.US)$$iMedia Brands(IMBI.US)$$CarMax(KMX.US)$$Mersana Therapeutics(MRSN.US)$$NVIDIA(NVDA.US)$$Oric Pharmaceuticals(ORIC.US)$$ProQR Therapeutics(PRQR.US)$$Rocket Pharmaceuticals(RCKT.US)$$Roku Inc(ROKU.US)$$Cassava Sciences(SAVA.US)$$Tesla(TSLA.US)$$Expion360(XPON.US)$
22/12: Let's go!!
No comment yet